Regulatory Credits definition

Regulatory Credits mean any all current and future credits, benefits, air quality credits, renewable fuel credits, renewable energy credits and certificates, emission reductions, offsets and allowances on the GHG Attributes, including, without limitation, RINs under the RFS Program, renewable energy certificates and credits under the LCFS and other state and provincial low carbon fuel programs such as LCFS credits.
Sample 1Sample 2Sample 3
Regulatory Credits means any credits under any program administered by a Governmental Authority, industry association, non-governmental organization, for-profit enterprise, or other entity, which has the effect of creating an economic incentive which can be attached to the environmental attributes of the Products produced by the Project, including, without limitation:
Sample 1
Regulatory Credits is defined in Section 7.4 of the Lease.
Sample 1

Examples of Regulatory Credits in a sentence

  • When specific identification of the particular source of the regulatory asset cannot be reasonably made, then FERC account 407.4 (Regulatory Credits) will be credited.

  • The recommendations stated in this document are economically and legally sound to our best knowledge, but cannot replace personal advice.

  • Revenues from other sales and services which are recognized at a point in time include (i) sales and installment of charging piles, (ii) sales of goods from online store, (iii) certain services under the Li Plus Membership, and (iv) sales of Automotive Regulatory Credits.

  • Specifically, it states that DEC falls back to the language applicable to amortizations included in Accounts 407.3 and 407.4 (Regulatory Credits), but does not acknowledge that the underlying Regulatory Assets and Liabilities have not been approved by the Commission as contractually required.36 24.

  • The regulatory asset had been established using Account No. 407.4 (Regulatory Credits) and the amortization expense had been recorded to Account 407.3 (Regulatory Debits).

  • Northeast Utilities also propose to amortize the regulatory liability to Account 407.4, Regulatory Credits, over the average life of assets in service as an offset to depreciation expense.

  • In addition, ALLETE is directed to amortize the Pre-funded AFUDC Regulatory Liability as an offset to depreciation expense by debiting Account 254 and crediting Account 407.4, Regulatory Credits.

  • PGE proposes to record the deferral as a regulatory asset in FERC Account 182.3 (Other Regulatory Assets), crediting FERC Account 407.4 (Regulatory Credits).

  • MidAmerican, however, must record the prefunded AFUDC regulatory liability in Account 254, Other Regulatory Liabilities, and amortize the regulatory liability by debiting Account 254 and crediting Account 407.4, Regulatory Credits.

  • Great River also proposes to amortize the regulatory liability to Account No. 407.4, Regulatory Credits, over the average in service life of the GRE CapX2020 Projects to serve as an offset to depreciation expense.B. Other Proposed Formula Rate Modifications 18.

Related to Regulatory Credits

  • Issuing authority means the authorized representative of the department of the City who issued the solicitation.

  • Regulatory Change means, with respect to any Lender, any change after the date hereof in Federal, state or foreign law or regulations (including, without limitation, Regulation D) or the adoption or making after such date of any interpretation, directive or request applying to a class of banks including such Lender of or under any Federal, state or foreign law or regulations (whether or not having the force of law and whether or not failure to comply therewith would be unlawful) by any court or governmental or monetary authority charged with the interpretation or administration thereof.

  • Regulatory Costs means, collectively, all future, supplemental, emergency or other changes in Reserve Percentages, assessment rates imposed by the FDIC, or similar requirements or costs imposed by any domestic or foreign governmental authority and related in any manner to the LIBO Rate, provided said amounts are actually paid by (or on behalf of) Lender.

  • by-product means a product which results from preparation of a fruit or vegetable product which has a positive economic value but is not the main intended result;

  • customs territory means the territory of the country of each Contracting Party in which the Customs laws of that country are in force;

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing, and control data, preclinical data, clinical data or all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product in the Field (including any Drug Master Files (DMFs), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • ISP98 means the International Standby Practices (1998 Revision, effective January 1, 1999), International Chamber of Commerce Publication No. 590.

  • Good Laboratory Practice or “GLP” means the applicable then-current standards for laboratory activities for pharmaceuticals (including biologicals) or vaccines, as applicable, as set forth in the Act and any regulations or guidance documents promulgated thereunder, as amended from time to time, together with any similar standards of good laboratory practice as are required by any Regulatory Authority having jurisdiction over the applicable activity.

  • Benchmarked Rates means the Framework Prices for the Benchmarked Services;

  • Customs authority means the authority that is responsible under the law of a Party for the administration and enforcement of customs laws and regulations; Customs duty includes any duty or charge of any kind imposed in connection with the importation of goods, but does not include any:

  • customs authorities means customs authorities as defined in Article 5, point (1), of Regulation (EU) No 952/2013;

  • Discriminatory practice means the violation of law referred to in Section 46a-51

  • Good Laboratory Practices or “GLP” means the then-current Good Laboratory Practice (or similar standards) for the performance of laboratory activities for pharmaceutical products as are required by applicable Regulatory Authorities or Applicable Law. In the United States, Good Laboratory Practices are established through FDA regulations (including 21 C.F.R. Part 58), FDA guidance, FDA current review and inspection standards and current industry standards.

  • Regulatory Capital means the capital requirement specified in Article 11;

  • GDP or “Gross Domestic Product” for the purposes of this LOA means the expenditure side value of all goods and services produced in British Columbia for a given year as stated in the BC Economic Accounts;

  • Unfair labor practice means the commission of an act designated an unfair labor practice

  • Resource Adequacy Rulings means CPUC Decisions 00-00-000, 00-00-000, 00-00-000, 06- 06-024, 00-00-000 and any subsequent CPUC ruling or decision, or any other resource adequacy laws, rules or regulations enacted, adopted or promulgated by any applicable Governmental Authority, as such CPUC decisions, rulings, laws, rules or regulations may be amended or modified from time to time during the Term.

  • Asset adequacy analysis means an analysis that meets the standards and other requirements referred to in 5.34(5)“d.”

  • ISP 98 means, with respect to any Letter of Credit, the “International Standby Practices 1998” published by the Institute of International Banking Law & Practice, Inc. (or such later version thereof as may be acceptable to the applicable Issuing Bank and in effect at the time of issuance of such Letter of Credit).

  • Practical application means to manufacture in the case of a composition or product, to practice in the case of a process or method, or to operate in the case of a machine or system; and, in each case, under such conditions as to establish that the invention is being utilized and that its benefits are, to the extent permitted by law or government regulations, available to the public on reasonable terms.

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • Regulatory Body means those government departments and regulatory, statutory and other entities, committees, ombudsmen and bodies which, whether under statute, rules, regulations, codes of practice or otherwise, are entitled to regulate or investigate the matters dealt with in this Agreement or any other affairs of the Provider or the Department, including, without limitation Ofsted, the European Commission and the European Court of Auditors;

  • Ancillary crime or "ancillary charge" means any delinquent act committed by a juvenile as a part

  • Balancing Authority means the responsible entity that integrates resource plans ahead of time, maintains load-interchange-generation balance within a Balancing Authority Area, and supports Interconnection frequency in real time.

  • Regulatory Exclusivity means any exclusive marketing rights or data exclusivity rights conferred by any Regulatory Authority with respect to a pharmaceutical product other than Patents, including orphan drug exclusivity, new chemical entity exclusivity, data exclusivity, or pediatric exclusivity.

  • Collaborative pharmacy practice means a practice of pharmacy whereby one or